BSE filing, NSE: HIKAL. Summary written from the filing by ALFA Finder's alert engine.
Hikal Ltd: key numbers
- Share price
- ₹204.40
- Market cap
- ₹2,520 Cr
- Revenue (annual)
- ₹1,713 Cr
- Net profit (annual)
- ₹-48.80 Cr
- P/E (TTM)
- -74.6×Sector 48.7×
- Promoter holding
- 68.85%+0.00% QoQ
- FII holding
- 1.28%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Hikal Ltd
All →Hikal Regulatory Approval
Hikal's Bengaluru API facility received a Swissmedic GMP Certificate of Compliance. The certification supports wider access to European and other regulated markets.
Hikal Other Announcement
Hikal Ltd filed its quarterly shareholding pattern for the period ended 30 September 2026. The filing reports routine ownership data with no new transaction.
Hikal Board Meeting Date
Hikal's board meets November 3, 2026 to consider September quarter and half-year results. The results are yet to be approved.
Hikal Other Announcement
Hikal Ltd filed its quarterly shareholding pattern for the period ending September 30, 2026, as required under SEBI Regulation 31(1)(b).
Hikal Management Change
Hikal Limited announced the cessation of Mr. Jai Hiremath as Executive Chairman and the resignation of Mrs. Sugandha Hiremath. Mr. Anish Swadi was appointed as CEO-Animal Health.
Hikal Other Announcement
Hikal Ltd. has been assigned an ESG rating of "Crisil ESG 65" by Crisil ESG Ratings & Analytics Limited, based on their independent assessment of public data.
Other annual general meeting announcements
All →Ashapuri Gold Ornament Annual General Meeting
Ashapuri Gold Ornament held its 18th AGM on 30 October 2026, transacting eight resolutions including auditor appointment and remuneration revisions. No transaction value is disclosed.
Wealth First Portfolio Managers Annual General Meeting
EGM notice seeks approval for preferential allotment and a ₹60 Crore RPT cap with Lakshya Asset Management. Meeting scheduled for November 21, 2026 via video conference.
Thyrocare Technologies Annual General Meeting
Thyrocare Technologies reported postal ballot voting results approving the purchase of land and building from, and divestment of its entire shareholding in, Nueclear Healthcare Limited.
Uravi Defence and Technology Annual General Meeting
Uravi Defence seeks postal ballot approval for up to Rs.6 Crore unsecured loans from directors. Remote e-voting runs October 30 to November 28, 2026.
Accord Synergy Annual General Meeting
Accord Synergy's postal ballot seeks approval for Mr. Betulla Khan's ₹5 lakh monthly remuneration as Business Development Head. E-voting closes November 30, 2026.
- Execution
- 1 year, 17 September 2026 to 16 September 2027
Globe Multi Ventures Annual General Meeting
Globe Multi Ventures filed proceedings of its 41st AGM held on October 29, 2026. E-voting results will follow after the scrutinizer's report.